A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis
Open Access
- 6 April 2006
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 20 (6) , 1055-1060
- https://doi.org/10.1038/sj.leu.2404209
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Inconsistencies in the association between the JAK2V617F mutation and PRV-1 over-expression among the chronic myeloproliferative diseasesBritish Journal of Haematology, 2006
- The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patientsBlood, 2005
- Abnormalities of GATA-1 in Megakaryocytes from Patients with Idiopathic MyelofibrosisThe American Journal of Pathology, 2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- The development of imatinib as a therapeutic agent for chronic myeloid leukemiaBlood, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- PRV-1 , erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemiaBritish Journal of Haematology, 2004
- Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosisBlood, 2003
- Diagnosis of the myeloproliferative disorders: Resolving phenotypic mimicrySeminars in Hematology, 2003